Reverting Colitis Symptoms by Oral Administration of L. reuteri Expressing CXCL12 Acting Through Novel Pathway Demonstrated in Two Experimental Animal Models

Öhnstedt E, Donas Cuadra C, Lofton Tomenius H, Frank P, Vågesjö E, Roos S, Phillipson M

The FASEB Journal 36 (S1) - [2022-05-00; online 2022-05-13]

DOI 10.1096/fasebj.2022.36.s1.l7872

Crossref 10.1096/fasebj.2022.36.s1.l7872